カテゴリー： Market Monitor Global, 世界, 医療/バイオ

核医学・放射性医薬品の世界市場見通し2023年-2029年

◆英語タイトル：Nuclear Medicine & Radiopharmaceutic Market, Global Outlook and Forecast 2023-2029

Market Monitor Globalが発行した調査報告書（MMG23JU5816）

◆商品コード：MMG23JU5816
◆発行会社（リサーチ会社）：Market Monitor Global
◆発行日：2023年6月
◆ページ数：70
◆レポート形式：英語 / PDF
◆納品方法：Eメール（受注後2-3営業日）
◆調査対象地域：グローバル、北米、アメリカ、ヨーロッパ、アジア、日本、中国、東南アジア、インド、南米、中東・アフリカなど
◆産業分野：医薬品＆医療

◆販売価格オプション（消費税別）

Single User（1名様閲覧用）	USD3,250 ⇒換算￥487,500	見積依頼/購入/質問フォーム
Multi User（20名様閲覧用）	USD4,225 ⇒換算￥633,750	見積依頼/購入/質問フォーム
Enterprise User（閲覧人数制限なし）	USD4,875 ⇒換算￥731,250	見積依頼/購入/質問フォーム

★Market Monitor Globalに受託調査の見積を依頼する

※販売価格オプションの説明はこちらで、ご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※Eメールによる納品の場合、通常ご注文当日～2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行・送付致します。（請求書発行日より2ヶ月以内の銀行振込条件、カード払いに変更可）
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。

❖ レポートの概要 ❖

Global Nuclear Medicine & Radiopharmaceutic Market 調査レポートは次の情報を含め、グローバルにおけるの核医学・放射性医薬品市場規模と予測を収録しています。・世界の核医学・放射性医薬品市場：売上、2018年-2023年、2024年-2029年
・世界の核医学・放射性医薬品市場：販売量、2018年-2023年、2024年-2029年
・世界のトップ5企業、2022年

世界の核医学・放射性医薬品市場は2022年に000Mドルと評価され、予測期間中に000％のCAGRで2029年までに000Mドルに達すると予測されています。アメリカ市場は2022年に000Mドルと推定されており、中国は2029年までに000Mドルに達すると予測されています。「Tc-99」セグメントは今後6年間、000%の年平均成長率で2029年までに000Mドルに成長すると予測されています。

核医学・放射性医薬品のグローバル主要企業は、GE Healthcare、 Bracco Imaging、 Mallinckrodt、 Lantheus Medical Imaging、 Bayer、 Jubilant Pharma、 Nordion、 Eli Lilly、 SIEMENS、 China Isotope & Radiation、 Yantai Dongcheng Biochemicalsなどです。2022年にトップ5企業がグローバル売上シェアの約000%を占めています。

マーケットモニターグローバル社は、核医学・放射性医薬品のメーカー、サプライヤー、流通業者、および業界の専門家を調査しました。これには、販売量、売上、需要、価格変動、製品タイプ、最近の動向と計画、産業トレンド、成長要因、課題、阻害要因、潜在的なリスクなどが含まれます。

【セグメント別マーケット分析】

世界の核医学・放射性医薬品市場：タイプ別、2018年-2023年、2024年-2029年
世界の核医学・放射性医薬品市場：タイプ別市場シェア、2022年
・Tc-99、I-123/131、In-111、Xe-133、Th-201、Ga-67、その他

世界の核医学・放射性医薬品市場：用途別、2018年-2023年、2024年-2029年
世界の核医学・放射性医薬品市場：用途別市場シェア、2022年
・診断、治療

世界の核医学・放射性医薬品市場：地域・国別、2018年-2023年、2024年-2029年
世界の核医学・放射性医薬品市場：地域別市場シェア、2022年
・北米：アメリカ、カナダ、メキシコ
・ヨーロッパ：ドイツ、フランス、イギリス、イタリア、ロシア
・アジア：中国、日本、韓国、東南アジア、インド
・南米：ブラジル、アルゼンチン
・中東・アフリカ：トルコ、イスラエル、サウジアラビア、UAE

【競争分析】

また、当レポートは主要な参入企業の分析を提供します。
・主要企業における核医学・放射性医薬品のグローバル売上、2018年-2023年
・主要企業における核医学・放射性医薬品のグローバル売上シェア、2022年
・主要企業における核医学・放射性医薬品のグローバル販売量、2018年-2023年
・主要企業における核医学・放射性医薬品のグローバル販売量シェア、2022年

さらに、当レポートは主要企業の情報を提示します。
GE Healthcare、 Bracco Imaging、 Mallinckrodt、 Lantheus Medical Imaging、 Bayer、 Jubilant Pharma、 Nordion、 Eli Lilly、 SIEMENS、 China Isotope & Radiation、 Yantai Dongcheng Biochemicals

*************************************************************

・調査・分析レポートの概要
核医学・放射性医薬品市場の定義
市場セグメント
世界の核医学・放射性医薬品市場概要
当レポートの特徴・ベネフィット
調査手法と情報源

・世界の核医学・放射性医薬品市場規模
世界の核医学・放射性医薬品市場規模：2022年 VS 2029年
世界の核医学・放射性医薬品市場規模と予測 2018年-2029年

・競争状況
グローバルトップ企業
売上ベースでのグローバルトップ企業
企業別グローバルでの核医学・放射性医薬品の売上
グローバルトップ3およびトップ5企業、2022年売上ベース
グローバル企業の核医学・放射性医薬品製品タイプ
グローバルにおけるティア1、ティア2、ティア3企業

・タイプ別市場分析
タイプ区分：Tc-99、I-123/131、In-111、Xe-133、Th-201、Ga-67、その他
核医学・放射性医薬品のタイプ別グローバル売上・予測

・用途別市場分析
用途区分：診断、治療
核医学・放射性医薬品の用途別グローバル売上・予測

・地域別市場分析
地域別核医学・放射性医薬品市場規模 2022年と2029年
地域別核医学・放射性医薬品売上・予測
北米市場：アメリカ、カナダ、メキシコ
ヨーロッパ市場：ドイツ、フランス、イギリス、イタリア、ロシア
アジア市場：中国、日本、韓国、東南アジア、インド
南米市場：ブラジル、アルゼンチン
中東・アフリカ市場：トルコ、イスラエル、サウジアラビア、UAE

・主要企業の情報（企業概要、事業概要、主要製品、売上、ニュースなど）
GE Healthcare、 Bracco Imaging、 Mallinckrodt、 Lantheus Medical Imaging、 Bayer、 Jubilant Pharma、 Nordion、 Eli Lilly、 SIEMENS、 China Isotope & Radiation、 Yantai Dongcheng Biochemicals
...

This report aims to provide a comprehensive presentation of the global market for Nuclear Medicine & Radiopharmaceutic, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Nuclear Medicine & Radiopharmaceutic. This report contains market size and forecasts of Nuclear Medicine & Radiopharmaceutic in global, including the following market information:
Global Nuclear Medicine & Radiopharmaceutic Market Revenue, 2018-2023, 2024-2029, ($ millions)
Global Nuclear Medicine & Radiopharmaceutic Market Sales, 2018-2023, 2024-2029, (Kiloton)
Global top five Nuclear Medicine & Radiopharmaceutic companies in 2022 (%)
The global Nuclear Medicine & Radiopharmaceutic market was valued at US$ million in 2022 and is projected to reach US$ million by 2029, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The U.S. Market is Estimated at $ Million in 2022, While China is Forecast to Reach $ Million.
Tc-99 Segment to Reach $ Million by 2029, with a % CAGR in next six years.
The global key manufacturers of Nuclear Medicine & Radiopharmaceutic include GE Healthcare, Bracco Imaging, Mallinckrodt, Lantheus Medical Imaging, Bayer, Jubilant Pharma, Nordion, Eli Lilly and SIEMENS, etc. in 2022, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Nuclear Medicine & Radiopharmaceutic manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Nuclear Medicine & Radiopharmaceutic Market, by Type, 2018-2023, 2024-2029 ($ Millions) & (Kiloton)
Global Nuclear Medicine & Radiopharmaceutic Market Segment Percentages, by Type, 2022 (%)
Tc-99
I-123/131
In-111
Xe-133
Th-201
Ga-67
Other
Global Nuclear Medicine & Radiopharmaceutic Market, by Application, 2018-2023, 2024-2029 ($ Millions) & (Kiloton)
Global Nuclear Medicine & Radiopharmaceutic Market Segment Percentages, by Application, 2022 (%)
Diagnostic
Therapeutic
Global Nuclear Medicine & Radiopharmaceutic Market, By Region and Country, 2018-2023, 2024-2029 ($ Millions) & (Kiloton)
Global Nuclear Medicine & Radiopharmaceutic Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Nuclear Medicine & Radiopharmaceutic revenues in global market, 2018-2023 (Estimated), ($ millions)
Key companies Nuclear Medicine & Radiopharmaceutic revenues share in global market, 2022 (%)
Key companies Nuclear Medicine & Radiopharmaceutic sales in global market, 2018-2023 (Estimated), (Kiloton)
Key companies Nuclear Medicine & Radiopharmaceutic sales share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
GE Healthcare
Bracco Imaging
Mallinckrodt
Lantheus Medical Imaging
Bayer
Jubilant Pharma
Nordion
Eli Lilly
SIEMENS
China Isotope & Radiation
Yantai Dongcheng Biochemicals
Outline of Major Chapters:
Chapter 1: Introduces the definition of Nuclear Medicine & Radiopharmaceutic, market overview.
Chapter 2: Global Nuclear Medicine & Radiopharmaceutic market size in revenue and volume.
Chapter 3: Detailed analysis of Nuclear Medicine & Radiopharmaceutic manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Nuclear Medicine & Radiopharmaceutic in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Global Nuclear Medicine & Radiopharmaceutic capacity by region & country.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 11: The main points and conclusions of the report.

❖ レポートの目次 ❖

1 Introduction to Research & Analysis Reports
1.1 Nuclear Medicine & Radiopharmaceutic Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Nuclear Medicine & Radiopharmaceutic Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Nuclear Medicine & Radiopharmaceutic Overall Market Size
2.1 Global Nuclear Medicine & Radiopharmaceutic Market Size: 2022 VS 2029
2.2 Global Nuclear Medicine & Radiopharmaceutic Revenue, Prospects & Forecasts: 2018-2029
2.3 Global Nuclear Medicine & Radiopharmaceutic Sales: 2018-2029
3 Company Landscape
3.1 Top Nuclear Medicine & Radiopharmaceutic Players in Global Market
3.2 Top Global Nuclear Medicine & Radiopharmaceutic Companies Ranked by Revenue
3.3 Global Nuclear Medicine & Radiopharmaceutic Revenue by Companies
3.4 Global Nuclear Medicine & Radiopharmaceutic Sales by Companies
3.5 Global Nuclear Medicine & Radiopharmaceutic Price by Manufacturer (2018-2023)
3.6 Top 3 and Top 5 Nuclear Medicine & Radiopharmaceutic Companies in Global Market, by Revenue in 2022
3.7 Global Manufacturers Nuclear Medicine & Radiopharmaceutic Product Type
3.8 Tier 1, Tier 2 and Tier 3 Nuclear Medicine & Radiopharmaceutic Players in Global Market
3.8.1 List of Global Tier 1 Nuclear Medicine & Radiopharmaceutic Companies
3.8.2 List of Global Tier 2 and Tier 3 Nuclear Medicine & Radiopharmaceutic Companies
4 Sights by Product
4.1 Overview
4.1.1 By Type – Global Nuclear Medicine & Radiopharmaceutic Market Size Markets, 2022 & 2029
4.1.2 Tc-99
4.1.3 I-123/131
4.1.4 In-111
4.1.5 Xe-133
4.1.6 Th-201
4.1.7 Ga-67
4.1.8 Other
4.2 By Type – Global Nuclear Medicine & Radiopharmaceutic Revenue & Forecasts
4.2.1 By Type – Global Nuclear Medicine & Radiopharmaceutic Revenue, 2018-2023
4.2.2 By Type – Global Nuclear Medicine & Radiopharmaceutic Revenue, 2024-2029
4.2.3 By Type – Global Nuclear Medicine & Radiopharmaceutic Revenue Market Share, 2018-2029
4.3 By Type – Global Nuclear Medicine & Radiopharmaceutic Sales & Forecasts
4.3.1 By Type – Global Nuclear Medicine & Radiopharmaceutic Sales, 2018-2023
4.3.2 By Type – Global Nuclear Medicine & Radiopharmaceutic Sales, 2024-2029
4.3.3 By Type – Global Nuclear Medicine & Radiopharmaceutic Sales Market Share, 2018-2029
4.4 By Type – Global Nuclear Medicine & Radiopharmaceutic Price (Manufacturers Selling Prices), 2018-2029
5 Sights by Application
5.1 Overview
5.1.1 By Application – Global Nuclear Medicine & Radiopharmaceutic Market Size, 2022 & 2029
5.1.2 Diagnostic
5.1.3 Therapeutic
5.2 By Application – Global Nuclear Medicine & Radiopharmaceutic Revenue & Forecasts
5.2.1 By Application – Global Nuclear Medicine & Radiopharmaceutic Revenue, 2018-2023
5.2.2 By Application – Global Nuclear Medicine & Radiopharmaceutic Revenue, 2024-2029
5.2.3 By Application – Global Nuclear Medicine & Radiopharmaceutic Revenue Market Share, 2018-2029
5.3 By Application – Global Nuclear Medicine & Radiopharmaceutic Sales & Forecasts
5.3.1 By Application – Global Nuclear Medicine & Radiopharmaceutic Sales, 2018-2023
5.3.2 By Application – Global Nuclear Medicine & Radiopharmaceutic Sales, 2024-2029
5.3.3 By Application – Global Nuclear Medicine & Radiopharmaceutic Sales Market Share, 2018-2029
5.4 By Application – Global Nuclear Medicine & Radiopharmaceutic Price (Manufacturers Selling Prices), 2018-2029
6 Sights by Region
6.1 By Region – Global Nuclear Medicine & Radiopharmaceutic Market Size, 2022 & 2029
6.2 By Region – Global Nuclear Medicine & Radiopharmaceutic Revenue & Forecasts
6.2.1 By Region – Global Nuclear Medicine & Radiopharmaceutic Revenue, 2018-2023
6.2.2 By Region – Global Nuclear Medicine & Radiopharmaceutic Revenue, 2024-2029
6.2.3 By Region – Global Nuclear Medicine & Radiopharmaceutic Revenue Market Share, 2018-2029
6.3 By Region – Global Nuclear Medicine & Radiopharmaceutic Sales & Forecasts
6.3.1 By Region – Global Nuclear Medicine & Radiopharmaceutic Sales, 2018-2023
6.3.2 By Region – Global Nuclear Medicine & Radiopharmaceutic Sales, 2024-2029
6.3.3 By Region – Global Nuclear Medicine & Radiopharmaceutic Sales Market Share, 2018-2029
6.4 North America
6.4.1 By Country – North America Nuclear Medicine & Radiopharmaceutic Revenue, 2018-2029
6.4.2 By Country – North America Nuclear Medicine & Radiopharmaceutic Sales, 2018-2029
6.4.3 US Nuclear Medicine & Radiopharmaceutic Market Size, 2018-2029
6.4.4 Canada Nuclear Medicine & Radiopharmaceutic Market Size, 2018-2029
6.4.5 Mexico Nuclear Medicine & Radiopharmaceutic Market Size, 2018-2029
6.5 Europe
6.5.1 By Country – Europe Nuclear Medicine & Radiopharmaceutic Revenue, 2018-2029
6.5.2 By Country – Europe Nuclear Medicine & Radiopharmaceutic Sales, 2018-2029
6.5.3 Germany Nuclear Medicine & Radiopharmaceutic Market Size, 2018-2029
6.5.4 France Nuclear Medicine & Radiopharmaceutic Market Size, 2018-2029
6.5.5 U.K. Nuclear Medicine & Radiopharmaceutic Market Size, 2018-2029
6.5.6 Italy Nuclear Medicine & Radiopharmaceutic Market Size, 2018-2029
6.5.7 Russia Nuclear Medicine & Radiopharmaceutic Market Size, 2018-2029
6.5.8 Nordic Countries Nuclear Medicine & Radiopharmaceutic Market Size, 2018-2029
6.5.9 Benelux Nuclear Medicine & Radiopharmaceutic Market Size, 2018-2029
6.6 Asia
6.6.1 By Region – Asia Nuclear Medicine & Radiopharmaceutic Revenue, 2018-2029
6.6.2 By Region – Asia Nuclear Medicine & Radiopharmaceutic Sales, 2018-2029
6.6.3 China Nuclear Medicine & Radiopharmaceutic Market Size, 2018-2029
6.6.4 Japan Nuclear Medicine & Radiopharmaceutic Market Size, 2018-2029
6.6.5 South Korea Nuclear Medicine & Radiopharmaceutic Market Size, 2018-2029
6.6.6 Southeast Asia Nuclear Medicine & Radiopharmaceutic Market Size, 2018-2029
6.6.7 India Nuclear Medicine & Radiopharmaceutic Market Size, 2018-2029
6.7 South America
6.7.1 By Country – South America Nuclear Medicine & Radiopharmaceutic Revenue, 2018-2029
6.7.2 By Country – South America Nuclear Medicine & Radiopharmaceutic Sales, 2018-2029
6.7.3 Brazil Nuclear Medicine & Radiopharmaceutic Market Size, 2018-2029
6.7.4 Argentina Nuclear Medicine & Radiopharmaceutic Market Size, 2018-2029
6.8 Middle East & Africa
6.8.1 By Country – Middle East & Africa Nuclear Medicine & Radiopharmaceutic Revenue, 2018-2029
6.8.2 By Country – Middle East & Africa Nuclear Medicine & Radiopharmaceutic Sales, 2018-2029
6.8.3 Turkey Nuclear Medicine & Radiopharmaceutic Market Size, 2018-2029
6.8.4 Israel Nuclear Medicine & Radiopharmaceutic Market Size, 2018-2029
6.8.5 Saudi Arabia Nuclear Medicine & Radiopharmaceutic Market Size, 2018-2029
6.8.6 UAE Nuclear Medicine & Radiopharmaceutic Market Size, 2018-2029
7 Manufacturers & Brands Profiles
7.1 GE Healthcare
7.1.1 GE Healthcare Company Summary
7.1.2 GE Healthcare Business Overview
7.1.3 GE Healthcare Nuclear Medicine & Radiopharmaceutic Major Product Offerings
7.1.4 GE Healthcare Nuclear Medicine & Radiopharmaceutic Sales and Revenue in Global (2018-2023)
7.1.5 GE Healthcare Key News & Latest Developments
7.2 Bracco Imaging
7.2.1 Bracco Imaging Company Summary
7.2.2 Bracco Imaging Business Overview
7.2.3 Bracco Imaging Nuclear Medicine & Radiopharmaceutic Major Product Offerings
7.2.4 Bracco Imaging Nuclear Medicine & Radiopharmaceutic Sales and Revenue in Global (2018-2023)
7.2.5 Bracco Imaging Key News & Latest Developments
7.3 Mallinckrodt
7.3.1 Mallinckrodt Company Summary
7.3.2 Mallinckrodt Business Overview
7.3.3 Mallinckrodt Nuclear Medicine & Radiopharmaceutic Major Product Offerings
7.3.4 Mallinckrodt Nuclear Medicine & Radiopharmaceutic Sales and Revenue in Global (2018-2023)
7.3.5 Mallinckrodt Key News & Latest Developments
7.4 Lantheus Medical Imaging
7.4.1 Lantheus Medical Imaging Company Summary
7.4.2 Lantheus Medical Imaging Business Overview
7.4.3 Lantheus Medical Imaging Nuclear Medicine & Radiopharmaceutic Major Product Offerings
7.4.4 Lantheus Medical Imaging Nuclear Medicine & Radiopharmaceutic Sales and Revenue in Global (2018-2023)
7.4.5 Lantheus Medical Imaging Key News & Latest Developments
7.5 Bayer
7.5.1 Bayer Company Summary
7.5.2 Bayer Business Overview
7.5.3 Bayer Nuclear Medicine & Radiopharmaceutic Major Product Offerings
7.5.4 Bayer Nuclear Medicine & Radiopharmaceutic Sales and Revenue in Global (2018-2023)
7.5.5 Bayer Key News & Latest Developments
7.6 Jubilant Pharma
7.6.1 Jubilant Pharma Company Summary
7.6.2 Jubilant Pharma Business Overview
7.6.3 Jubilant Pharma Nuclear Medicine & Radiopharmaceutic Major Product Offerings
7.6.4 Jubilant Pharma Nuclear Medicine & Radiopharmaceutic Sales and Revenue in Global (2018-2023)
7.6.5 Jubilant Pharma Key News & Latest Developments
7.7 Nordion
7.7.1 Nordion Company Summary
7.7.2 Nordion Business Overview
7.7.3 Nordion Nuclear Medicine & Radiopharmaceutic Major Product Offerings
7.7.4 Nordion Nuclear Medicine & Radiopharmaceutic Sales and Revenue in Global (2018-2023)
7.7.5 Nordion Key News & Latest Developments
7.8 Eli Lilly
7.8.1 Eli Lilly Company Summary
7.8.2 Eli Lilly Business Overview
7.8.3 Eli Lilly Nuclear Medicine & Radiopharmaceutic Major Product Offerings
7.8.4 Eli Lilly Nuclear Medicine & Radiopharmaceutic Sales and Revenue in Global (2018-2023)
7.8.5 Eli Lilly Key News & Latest Developments
7.9 SIEMENS
7.9.1 SIEMENS Company Summary
7.9.2 SIEMENS Business Overview
7.9.3 SIEMENS Nuclear Medicine & Radiopharmaceutic Major Product Offerings
7.9.4 SIEMENS Nuclear Medicine & Radiopharmaceutic Sales and Revenue in Global (2018-2023)
7.9.5 SIEMENS Key News & Latest Developments
7.10 China Isotope & Radiation
7.10.1 China Isotope & Radiation Company Summary
7.10.2 China Isotope & Radiation Business Overview
7.10.3 China Isotope & Radiation Nuclear Medicine & Radiopharmaceutic Major Product Offerings
7.10.4 China Isotope & Radiation Nuclear Medicine & Radiopharmaceutic Sales and Revenue in Global (2018-2023)
7.10.5 China Isotope & Radiation Key News & Latest Developments
7.11 Yantai Dongcheng Biochemicals
7.11.1 Yantai Dongcheng Biochemicals Company Summary
7.11.2 Yantai Dongcheng Biochemicals Nuclear Medicine & Radiopharmaceutic Business Overview
7.11.3 Yantai Dongcheng Biochemicals Nuclear Medicine & Radiopharmaceutic Major Product Offerings
7.11.4 Yantai Dongcheng Biochemicals Nuclear Medicine & Radiopharmaceutic Sales and Revenue in Global (2018-2023)
7.11.5 Yantai Dongcheng Biochemicals Key News & Latest Developments
8 Global Nuclear Medicine & Radiopharmaceutic Production Capacity, Analysis
8.1 Global Nuclear Medicine & Radiopharmaceutic Production Capacity, 2018-2029
8.2 Nuclear Medicine & Radiopharmaceutic Production Capacity of Key Manufacturers in Global Market
8.3 Global Nuclear Medicine & Radiopharmaceutic Production by Region
9 Key Market Trends, Opportunity, Drivers and Restraints
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 Nuclear Medicine & Radiopharmaceutic Supply Chain Analysis
10.1 Nuclear Medicine & Radiopharmaceutic Industry Value Chain
10.2 Nuclear Medicine & Radiopharmaceutic Upstream Market
10.3 Nuclear Medicine & Radiopharmaceutic Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 Nuclear Medicine & Radiopharmaceutic Distributors and Sales Agents in Global
11 Conclusion
12 Appendix
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer

List of Tables
Table 1. Key Players of Nuclear Medicine & Radiopharmaceutic in Global Market
Table 2. Top Nuclear Medicine & Radiopharmaceutic Players in Global Market, Ranking by Revenue (2022)
Table 3. Global Nuclear Medicine & Radiopharmaceutic Revenue by Companies, (US$, Mn), 2018-2023
Table 4. Global Nuclear Medicine & Radiopharmaceutic Revenue Share by Companies, 2018-2023
Table 5. Global Nuclear Medicine & Radiopharmaceutic Sales by Companies, (Kiloton), 2018-2023
Table 6. Global Nuclear Medicine & Radiopharmaceutic Sales Share by Companies, 2018-2023
Table 7. Key Manufacturers Nuclear Medicine & Radiopharmaceutic Price (2018-2023) & (US$/Ton)
Table 8. Global Manufacturers Nuclear Medicine & Radiopharmaceutic Product Type
Table 9. List of Global Tier 1 Nuclear Medicine & Radiopharmaceutic Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Nuclear Medicine & Radiopharmaceutic Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 11. By Type – Global Nuclear Medicine & Radiopharmaceutic Revenue, (US$, Mn), 2022 & 2029
Table 12. By Type - Global Nuclear Medicine & Radiopharmaceutic Revenue (US$, Mn), 2018-2023
Table 13. By Type - Global Nuclear Medicine & Radiopharmaceutic Revenue (US$, Mn), 2024-2029
Table 14. By Type - Global Nuclear Medicine & Radiopharmaceutic Sales (Kiloton), 2018-2023
Table 15. By Type - Global Nuclear Medicine & Radiopharmaceutic Sales (Kiloton), 2024-2029
Table 16. By Application – Global Nuclear Medicine & Radiopharmaceutic Revenue, (US$, Mn), 2022 & 2029
Table 17. By Application - Global Nuclear Medicine & Radiopharmaceutic Revenue (US$, Mn), 2018-2023
Table 18. By Application - Global Nuclear Medicine & Radiopharmaceutic Revenue (US$, Mn), 2024-2029
Table 19. By Application - Global Nuclear Medicine & Radiopharmaceutic Sales (Kiloton), 2018-2023
Table 20. By Application - Global Nuclear Medicine & Radiopharmaceutic Sales (Kiloton), 2024-2029
Table 21. By Region – Global Nuclear Medicine & Radiopharmaceutic Revenue, (US$, Mn), 2022 VS 2029
Table 22. By Region - Global Nuclear Medicine & Radiopharmaceutic Revenue (US$, Mn), 2018-2023
Table 23. By Region - Global Nuclear Medicine & Radiopharmaceutic Revenue (US$, Mn), 2024-2029
Table 24. By Region - Global Nuclear Medicine & Radiopharmaceutic Sales (Kiloton), 2018-2023
Table 25. By Region - Global Nuclear Medicine & Radiopharmaceutic Sales (Kiloton), 2024-2029
Table 26. By Country - North America Nuclear Medicine & Radiopharmaceutic Revenue, (US$, Mn), 2018-2023
Table 27. By Country - North America Nuclear Medicine & Radiopharmaceutic Revenue, (US$, Mn), 2024-2029
Table 28. By Country - North America Nuclear Medicine & Radiopharmaceutic Sales, (Kiloton), 2018-2023
Table 29. By Country - North America Nuclear Medicine & Radiopharmaceutic Sales, (Kiloton), 2024-2029
Table 30. By Country - Europe Nuclear Medicine & Radiopharmaceutic Revenue, (US$, Mn), 2018-2023
Table 31. By Country - Europe Nuclear Medicine & Radiopharmaceutic Revenue, (US$, Mn), 2024-2029
Table 32. By Country - Europe Nuclear Medicine & Radiopharmaceutic Sales, (Kiloton), 2018-2023
Table 33. By Country - Europe Nuclear Medicine & Radiopharmaceutic Sales, (Kiloton), 2024-2029
Table 34. By Region - Asia Nuclear Medicine & Radiopharmaceutic Revenue, (US$, Mn), 2018-2023
Table 35. By Region - Asia Nuclear Medicine & Radiopharmaceutic Revenue, (US$, Mn), 2024-2029
Table 36. By Region - Asia Nuclear Medicine & Radiopharmaceutic Sales, (Kiloton), 2018-2023
Table 37. By Region - Asia Nuclear Medicine & Radiopharmaceutic Sales, (Kiloton), 2024-2029
Table 38. By Country - South America Nuclear Medicine & Radiopharmaceutic Revenue, (US$, Mn), 2018-2023
Table 39. By Country - South America Nuclear Medicine & Radiopharmaceutic Revenue, (US$, Mn), 2024-2029
Table 40. By Country - South America Nuclear Medicine & Radiopharmaceutic Sales, (Kiloton), 2018-2023
Table 41. By Country - South America Nuclear Medicine & Radiopharmaceutic Sales, (Kiloton), 2024-2029
Table 42. By Country - Middle East & Africa Nuclear Medicine & Radiopharmaceutic Revenue, (US$, Mn), 2018-2023
Table 43. By Country - Middle East & Africa Nuclear Medicine & Radiopharmaceutic Revenue, (US$, Mn), 2024-2029
Table 44. By Country - Middle East & Africa Nuclear Medicine & Radiopharmaceutic Sales, (Kiloton), 2018-2023
Table 45. By Country - Middle East & Africa Nuclear Medicine & Radiopharmaceutic Sales, (Kiloton), 2024-2029
Table 46. GE Healthcare Company Summary
Table 47. GE Healthcare Nuclear Medicine & Radiopharmaceutic Product Offerings
Table 48. GE Healthcare Nuclear Medicine & Radiopharmaceutic Sales (Kiloton), Revenue (US$, Mn) and Average Price (US$/Ton) (2018-2023)
Table 49. GE Healthcare Key News & Latest Developments
Table 50. Bracco Imaging Company Summary
Table 51. Bracco Imaging Nuclear Medicine & Radiopharmaceutic Product Offerings
Table 52. Bracco Imaging Nuclear Medicine & Radiopharmaceutic Sales (Kiloton), Revenue (US$, Mn) and Average Price (US$/Ton) (2018-2023)
Table 53. Bracco Imaging Key News & Latest Developments
Table 54. Mallinckrodt Company Summary
Table 55. Mallinckrodt Nuclear Medicine & Radiopharmaceutic Product Offerings
Table 56. Mallinckrodt Nuclear Medicine & Radiopharmaceutic Sales (Kiloton), Revenue (US$, Mn) and Average Price (US$/Ton) (2018-2023)
Table 57. Mallinckrodt Key News & Latest Developments
Table 58. Lantheus Medical Imaging Company Summary
Table 59. Lantheus Medical Imaging Nuclear Medicine & Radiopharmaceutic Product Offerings
Table 60. Lantheus Medical Imaging Nuclear Medicine & Radiopharmaceutic Sales (Kiloton), Revenue (US$, Mn) and Average Price (US$/Ton) (2018-2023)
Table 61. Lantheus Medical Imaging Key News & Latest Developments
Table 62. Bayer Company Summary
Table 63. Bayer Nuclear Medicine & Radiopharmaceutic Product Offerings
Table 64. Bayer Nuclear Medicine & Radiopharmaceutic Sales (Kiloton), Revenue (US$, Mn) and Average Price (US$/Ton) (2018-2023)
Table 65. Bayer Key News & Latest Developments
Table 66. Jubilant Pharma Company Summary
Table 67. Jubilant Pharma Nuclear Medicine & Radiopharmaceutic Product Offerings
Table 68. Jubilant Pharma Nuclear Medicine & Radiopharmaceutic Sales (Kiloton), Revenue (US$, Mn) and Average Price (US$/Ton) (2018-2023)
Table 69. Jubilant Pharma Key News & Latest Developments
Table 70. Nordion Company Summary
Table 71. Nordion Nuclear Medicine & Radiopharmaceutic Product Offerings
Table 72. Nordion Nuclear Medicine & Radiopharmaceutic Sales (Kiloton), Revenue (US$, Mn) and Average Price (US$/Ton) (2018-2023)
Table 73. Nordion Key News & Latest Developments
Table 74. Eli Lilly Company Summary
Table 75. Eli Lilly Nuclear Medicine & Radiopharmaceutic Product Offerings
Table 76. Eli Lilly Nuclear Medicine & Radiopharmaceutic Sales (Kiloton), Revenue (US$, Mn) and Average Price (US$/Ton) (2018-2023)
Table 77. Eli Lilly Key News & Latest Developments
Table 78. SIEMENS Company Summary
Table 79. SIEMENS Nuclear Medicine & Radiopharmaceutic Product Offerings
Table 80. SIEMENS Nuclear Medicine & Radiopharmaceutic Sales (Kiloton), Revenue (US$, Mn) and Average Price (US$/Ton) (2018-2023)
Table 81. SIEMENS Key News & Latest Developments
Table 82. China Isotope & Radiation Company Summary
Table 83. China Isotope & Radiation Nuclear Medicine & Radiopharmaceutic Product Offerings
Table 84. China Isotope & Radiation Nuclear Medicine & Radiopharmaceutic Sales (Kiloton), Revenue (US$, Mn) and Average Price (US$/Ton) (2018-2023)
Table 85. China Isotope & Radiation Key News & Latest Developments
Table 86. Yantai Dongcheng Biochemicals Company Summary
Table 87. Yantai Dongcheng Biochemicals Nuclear Medicine & Radiopharmaceutic Product Offerings
Table 88. Yantai Dongcheng Biochemicals Nuclear Medicine & Radiopharmaceutic Sales (Kiloton), Revenue (US$, Mn) and Average Price (US$/Ton) (2018-2023)
Table 89. Yantai Dongcheng Biochemicals Key News & Latest Developments
Table 90. Nuclear Medicine & Radiopharmaceutic Production Capacity (Kiloton) of Key Manufacturers in Global Market, 2021-2023 (Kiloton)
Table 91. Global Nuclear Medicine & Radiopharmaceutic Capacity Market Share of Key Manufacturers, 2021-2023
Table 92. Global Nuclear Medicine & Radiopharmaceutic Production by Region, 2018-2023 (Kiloton)
Table 93. Global Nuclear Medicine & Radiopharmaceutic Production by Region, 2024-2029 (Kiloton)
Table 94. Nuclear Medicine & Radiopharmaceutic Market Opportunities & Trends in Global Market
Table 95. Nuclear Medicine & Radiopharmaceutic Market Drivers in Global Market
Table 96. Nuclear Medicine & Radiopharmaceutic Market Restraints in Global Market
Table 97. Nuclear Medicine & Radiopharmaceutic Raw Materials
Table 98. Nuclear Medicine & Radiopharmaceutic Raw Materials Suppliers in Global Market
Table 99. Typical Nuclear Medicine & Radiopharmaceutic Downstream
Table 100. Nuclear Medicine & Radiopharmaceutic Downstream Clients in Global Market
Table 101. Nuclear Medicine & Radiopharmaceutic Distributors and Sales Agents in Global Market
List of Figures
Figure 1. Nuclear Medicine & Radiopharmaceutic Segment by Type in 2022
Figure 2. Nuclear Medicine & Radiopharmaceutic Segment by Application in 2022
Figure 3. Global Nuclear Medicine & Radiopharmaceutic Market Overview: 2022
Figure 4. Key Caveats
Figure 5. Global Nuclear Medicine & Radiopharmaceutic Market Size: 2022 VS 2029 (US$, Mn)
Figure 6. Global Nuclear Medicine & Radiopharmaceutic Revenue, 2018-2029 (US$, Mn)
Figure 7. Nuclear Medicine & Radiopharmaceutic Sales in Global Market: 2018-2029 (Kiloton)
Figure 8. The Top 3 and 5 Players Market Share by Nuclear Medicine & Radiopharmaceutic Revenue in 2022
Figure 9. By Type - Global Nuclear Medicine & Radiopharmaceutic Revenue, (US$, Mn), 2022 & 2029
Figure 10. By Type - Global Nuclear Medicine & Radiopharmaceutic Revenue Market Share, 2018-2029
Figure 11. By Type - Global Nuclear Medicine & Radiopharmaceutic Sales Market Share, 2018-2029
Figure 12. By Type - Global Nuclear Medicine & Radiopharmaceutic Price (US$/Ton), 2018-2029
Figure 13. By Application - Global Nuclear Medicine & Radiopharmaceutic Revenue, (US$, Mn), 2022 & 2029
Figure 14. By Application - Global Nuclear Medicine & Radiopharmaceutic Revenue Market Share, 2018-2029
Figure 15. By Application - Global Nuclear Medicine & Radiopharmaceutic Sales Market Share, 2018-2029
Figure 16. By Application - Global Nuclear Medicine & Radiopharmaceutic Price (US$/Ton), 2018-2029
Figure 17. By Region - Global Nuclear Medicine & Radiopharmaceutic Revenue, (US$, Mn), 2022 & 2029
Figure 18. By Region - Global Nuclear Medicine & Radiopharmaceutic Revenue Market Share, 2018 VS 2022 VS 2029
Figure 19. By Region - Global Nuclear Medicine & Radiopharmaceutic Revenue Market Share, 2018-2029
Figure 20. By Region - Global Nuclear Medicine & Radiopharmaceutic Sales Market Share, 2018-2029
Figure 21. By Country - North America Nuclear Medicine & Radiopharmaceutic Revenue Market Share, 2018-2029
Figure 22. By Country - North America Nuclear Medicine & Radiopharmaceutic Sales Market Share, 2018-2029
Figure 23. US Nuclear Medicine & Radiopharmaceutic Revenue, (US$, Mn), 2018-2029
Figure 24. Canada Nuclear Medicine & Radiopharmaceutic Revenue, (US$, Mn), 2018-2029
Figure 25. Mexico Nuclear Medicine & Radiopharmaceutic Revenue, (US$, Mn), 2018-2029
Figure 26. By Country - Europe Nuclear Medicine & Radiopharmaceutic Revenue Market Share, 2018-2029
Figure 27. By Country - Europe Nuclear Medicine & Radiopharmaceutic Sales Market Share, 2018-2029
Figure 28. Germany Nuclear Medicine & Radiopharmaceutic Revenue, (US$, Mn), 2018-2029
Figure 29. France Nuclear Medicine & Radiopharmaceutic Revenue, (US$, Mn), 2018-2029
Figure 30. U.K. Nuclear Medicine & Radiopharmaceutic Revenue, (US$, Mn), 2018-2029
Figure 31. Italy Nuclear Medicine & Radiopharmaceutic Revenue, (US$, Mn), 2018-2029
Figure 32. Russia Nuclear Medicine & Radiopharmaceutic Revenue, (US$, Mn), 2018-2029
Figure 33. Nordic Countries Nuclear Medicine & Radiopharmaceutic Revenue, (US$, Mn), 2018-2029
Figure 34. Benelux Nuclear Medicine & Radiopharmaceutic Revenue, (US$, Mn), 2018-2029
Figure 35. By Region - Asia Nuclear Medicine & Radiopharmaceutic Revenue Market Share, 2018-2029
Figure 36. By Region - Asia Nuclear Medicine & Radiopharmaceutic Sales Market Share, 2018-2029
Figure 37. China Nuclear Medicine & Radiopharmaceutic Revenue, (US$, Mn), 2018-2029
Figure 38. Japan Nuclear Medicine & Radiopharmaceutic Revenue, (US$, Mn), 2018-2029
Figure 39. South Korea Nuclear Medicine & Radiopharmaceutic Revenue, (US$, Mn), 2018-2029
Figure 40. Southeast Asia Nuclear Medicine & Radiopharmaceutic Revenue, (US$, Mn), 2018-2029
Figure 41. India Nuclear Medicine & Radiopharmaceutic Revenue, (US$, Mn), 2018-2029
Figure 42. By Country - South America Nuclear Medicine & Radiopharmaceutic Revenue Market Share, 2018-2029
Figure 43. By Country - South America Nuclear Medicine & Radiopharmaceutic Sales Market Share, 2018-2029
Figure 44. Brazil Nuclear Medicine & Radiopharmaceutic Revenue, (US$, Mn), 2018-2029
Figure 45. Argentina Nuclear Medicine & Radiopharmaceutic Revenue, (US$, Mn), 2018-2029
Figure 46. By Country - Middle East & Africa Nuclear Medicine & Radiopharmaceutic Revenue Market Share, 2018-2029
Figure 47. By Country - Middle East & Africa Nuclear Medicine & Radiopharmaceutic Sales Market Share, 2018-2029
Figure 48. Turkey Nuclear Medicine & Radiopharmaceutic Revenue, (US$, Mn), 2018-2029
Figure 49. Israel Nuclear Medicine & Radiopharmaceutic Revenue, (US$, Mn), 2018-2029
Figure 50. Saudi Arabia Nuclear Medicine & Radiopharmaceutic Revenue, (US$, Mn), 2018-2029
Figure 51. UAE Nuclear Medicine & Radiopharmaceutic Revenue, (US$, Mn), 2018-2029
Figure 52. Global Nuclear Medicine & Radiopharmaceutic Production Capacity (Kiloton), 2018-2029
Figure 53. The Percentage of Production Nuclear Medicine & Radiopharmaceutic by Region, 2022 VS 2029
Figure 54. Nuclear Medicine & Radiopharmaceutic Industry Value Chain
Figure 55. Marketing Channels

❖ 免責事項 ❖
http://www.globalresearch.jp/disclaimer

★リサーチレポート[ 核医学・放射性医薬品の世界市場見通し2023年-2029年(Nuclear Medicine & Radiopharmaceutic Market, Global Outlook and Forecast 2023-2029)]についてメールでお問い合わせはこちらでお願いします。

GlobalResearch.jp

核医学・放射性医薬品の世界市場見通し2023年-2029年

グローバル市場調査/マーケットリサーチ会社：レポート販売と委託調査サービス提供 www.GlobalResearch.jp